These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 19700023)
1. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. Hong JB; Su YN; Chiu HC J Am Acad Dermatol; 2009 Sep; 61(3):533-5. PubMed ID: 19700023 [No Abstract] [Full Text] [Related]
2. Peculiarities of PAPA syndrome. Tallon B; Corkill M Rheumatology (Oxford); 2006 Sep; 45(9):1140-3. PubMed ID: 16527883 [TBL] [Abstract][Full Text] [Related]
3. A sporadic case of pyogenic arthritis, pyoderma gangrenosum and acne syndrome without an identifiable mutation. Park BM; Yun SJ; Lee SC; Lee JB Clin Exp Dermatol; 2014 Jan; 39(1):73-5. PubMed ID: 23692517 [No Abstract] [Full Text] [Related]
4. Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome. Lindwall E; Singla S; Davis WE; Quinet RJ Semin Arthritis Rheum; 2015 Aug; 45(1):91-3. PubMed ID: 25845478 [TBL] [Abstract][Full Text] [Related]
5. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab. Lee H; Park SH; Kim SK; Choe JY; Park JS Clin Exp Rheumatol; 2012; 30(3):452. PubMed ID: 22513199 [No Abstract] [Full Text] [Related]
6. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. Marzano AV; Trevisan V; Gattorno M; Ceccherini I; De Simone C; Crosti C JAMA Dermatol; 2013 Jun; 149(6):762-4. PubMed ID: 23571383 [No Abstract] [Full Text] [Related]
7. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Stichweh DS; Punaro M; Pascual V Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580 [TBL] [Abstract][Full Text] [Related]
8. A novel de novo PSTPIP1 mutation in a boy with pyogenic arthritis, pyoderma gangrenosum, acne (PAPA) syndrome. Fathalla BM; Al-Wahadneh AM; Al-Mutawa M; Kambouris M; El-Shanti H Clin Exp Rheumatol; 2014; 32(6):956-8. PubMed ID: 24960411 [TBL] [Abstract][Full Text] [Related]
9. Case Report: Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne: A Single-Center Experience and Literature Review. Wang Y; Wu N; Yu K; Shen M Front Immunol; 2021; 12():735851. PubMed ID: 34745107 [TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum, acne and ulcerative colitis in a patient with a novel mutation in the PSTPIP1 gene. Zeeli T; Padalon-Brauch G; Ellenbogen E; Gat A; Sarig O; Sprecher E Clin Exp Dermatol; 2015 Jun; 40(4):367-72. PubMed ID: 25683018 [TBL] [Abstract][Full Text] [Related]
11. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Demidowich AP; Freeman AF; Kuhns DB; Aksentijevich I; Gallin JI; Turner ML; Kastner DL; Holland SM Arthritis Rheum; 2012 Jun; 64(6):2022-7. PubMed ID: 22161697 [TBL] [Abstract][Full Text] [Related]
13. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Lindor NM; Arsenault TM; Solomon H; Seidman CE; McEvoy MT Mayo Clin Proc; 1997 Jul; 72(7):611-5. PubMed ID: 9212761 [TBL] [Abstract][Full Text] [Related]
14. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. Geusau A; Mothes-Luksch N; Nahavandi H; Pickl WF; Wise CA; Pourpak Z; Ponweiser E; Eckhart L; Sunder-Plassmann R JAMA Dermatol; 2013 Feb; 149(2):209-15. PubMed ID: 23426477 [TBL] [Abstract][Full Text] [Related]
15. The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations: from PAPA to PAMI syndrome and beyond. Klötgen HW; Beltraminelli H; Yawalkar N; van Gijn ME; Holzinger D; Borradori L Br J Dermatol; 2018 Apr; 178(4):982-983. PubMed ID: 29150835 [No Abstract] [Full Text] [Related]
16. First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome. Duchatelet S; Miskinyte S; Join-Lambert O; Ungeheuer MN; Francès C; Nassif A; Hovnanian A Br J Dermatol; 2015 Aug; 173(2):610-2. PubMed ID: 25601011 [No Abstract] [Full Text] [Related]
17. Abnormal production of tumor necrosis factor (TNF) -- alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected]. Cortis E; De Benedetti F; Insalaco A; Cioschi S; Muratori F; D'Urbano LE; Ugazio AG J Pediatr; 2004 Dec; 145(6):851-5. PubMed ID: 15580218 [TBL] [Abstract][Full Text] [Related]
18. Inflammation in mice ectopically expressing human Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome-associated PSTPIP1 A230T mutant proteins. Wang D; Höing S; Patterson HC; Ahmad UM; Rathinam VA; Rajewsky K; Fitzgerald KA; Golenbock DT J Biol Chem; 2013 Feb; 288(7):4594-601. PubMed ID: 23293022 [TBL] [Abstract][Full Text] [Related]
19. Impaired podosome formation and invasive migration of macrophages from patients with a PSTPIP1 mutation and PAPA syndrome. Cortesio CL; Wernimont SA; Kastner DL; Cooper KM; Huttenlocher A Arthritis Rheum; 2010 Aug; 62(8):2556-8. PubMed ID: 20506269 [No Abstract] [Full Text] [Related]